UNITED THERAPEUTICS Corp 4

United Therapeutics director Jan Malcolm received an annual equity compensation grant of 380 RSUs and stock options for 1,190 shares of common stock on July 22, 2026.

On July 22, 2026, United Therapeutics Corporation non‑employee director Jan Malcolm received an annual equity compensation package consisting of 380 restricted stock units (RSUs) and stock options for 1,190 shares of common stock, both reported as awards under transaction code “A.” The RSUs, which convert one‑for‑one into common shares upon vesting, and the options are part of the company’s routine annual non‑employee director grants that become fully vested on the earlier of the one‑year anniversary of the grant date or the anticipated June 25, 2027 annual shareholder meeting. Following these grants, Malcolm’s directly owned common stock holdings were reported as 450 shares, with additional 380 shares underlying RSUs and 1,190 shares underlying options, reflecting standard, non‑open‑market, compensation‑related equity awards rather than discretionary purchases or sales.

Filing Facts

CIK

1082554

Ticker

UTHR

Form

4

Source Type

fda

Accession

0002028640-26-000008

Alert Tier

5